Chennai Meenakshi Multispeciality Hospital Limited will hold a meeting of its Board of Directors on August 7, 2026, to approve the appointment of M. Karunakaran as an Additional Independent Director. The session, scheduled for 12:30 PM IST, will be conducted via video conference and convened at short notice under Section 173(3) of the Companies Act, 2013, and SS-1. The company confirmed that the required consent from existing independent directors has been obtained to facilitate this short-notice convening.

The primary agenda for the board meeting is to consider and approve the appointment of M. Karunakaran, who holds Director Identification Number (DIN) 11874200. This appointment aims to strengthen the company’s governance structure by adding an independent voice to the boardroom. The decision aligns with regulatory requirements for independent director representation listed entities must maintain.

Meeting Details and Regulatory Compliance

The board meeting is being organized in adherence to Regulation 29 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. These regulations mandate timely disclosure of board meetings and their agendas to stock exchanges and investors. By notifying the BSE Limited on August 6, 2026, the company ensured transparency regarding the upcoming corporate action.

The use of video conferencing reflects standard practices for efficient board governance, allowing directors to participate remotely while maintaining quorum and legal validity. The short-notice provision was utilized with the necessary consents, ensuring that the procedural integrity of the meeting remains intact despite the compressed timeline.

Governance Implications

The appointment of an additional independent director is a significant step for Chennai Meenakshi Multispeciality Hospital Limited’s corporate governance framework. Independent directors play a crucial role in providing objective oversight, protecting minority shareholder interests, and ensuring ethical business practices. Their presence helps balance management influence and enhances decision-making quality.

M. Karunakaran’s addition to the board will contribute to this objective. As an independent director, he will not be involved in day-to-day management but will focus on strategic guidance and risk oversight. This move underscores the company’s commitment to maintaining robust governance standards as it continues to operate in the competitive healthcare sector.

Company Background

Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, is a prominent healthcare provider based in Chennai. The hospital holds NABH accreditation and ISO 9001:2008 / ISO 14001:2004 certifications, reflecting its adherence to high-quality patient care and environmental management standards. With its registered office at Luz Church Road, Mylapore, the institution serves a significant portion of the region’s healthcare needs.

The company’s proactive approach to board composition demonstrates its dedication to long-term sustainability and stakeholder trust. By regularly reviewing and enhancing its leadership structure, Chennai Meenakshi Multispeciality Hospital Limited positions itself to navigate future challenges effectively while maintaining operational excellence.

Dr. Venkataraman Krishnamurthy has resigned as Chief Executive Officer of chennai meenakshi multispeciality effective from the close of business hours on June 15, 2026, due to personal reasons. The company disclosed that there are no other material reasons for his departure. The resignation was intimated to BSE pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

The company submitted the necessary disclosures to the stock exchange, including the resignation letter dated June 15, 2026. The communication was signed by M. S. Anantha Lakshmi, Company Secretary and Compliance Officer.

In his resignation letter addressed to the Board of Directors, Dr. Krishnamurthy expressed gratitude to the Board, promoters, and the management team for their support during his tenure. He confirmed that he would ensure a smooth transition of his responsibilities before his exit.